Involvement of 5-HT1A activity in the discriminative stimulus effects of imipramine
暂无分享,去创建一个
[1] J. Barrett,et al. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. , 1992, European journal of pharmacology.
[2] J. Barrett,et al. Imipramine as a discriminative stimulus. , 1991, The Journal of pharmacology and experimental therapeutics.
[3] D. Stephens,et al. Drug discrimination models in anxiety and depression. , 1990, Pharmacology & therapeutics.
[4] M. Bijak. Antidepressant drugs potentiate the α1-adrenoceptor effect in hippocampal slices , 1989 .
[5] R. Glennon,et al. Stimulus properties of arylpiperazines: NAN‐190, a potential 5‐HT1A serotonin antagonist , 1989 .
[6] C. Montigny,et al. Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment , 1989, Synapse.
[7] R. Glennon,et al. NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). , 1988, European journal of pharmacology.
[8] B. Lerer,et al. Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. , 1988, European journal of pharmacology.
[9] P. Soubrié,et al. Reversal of helpless behavior in rats by putative 5-HT1A agonists , 1988, Biological Psychiatry.
[10] M. Lader. Long-term anxiolytic therapy: the issue of drug withdrawal. , 1987, The Journal of clinical psychiatry.
[11] K. Rickels,et al. Gepirone in Anxiety: A Pilot Study , 1987, Journal of clinical psychopharmacology.
[12] S. Maayani,et al. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. , 1985, European journal of pharmacology.
[13] G. Goodwin,et al. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock , 1985, Nature.